SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000886163-21-000050
Filing Date
2021-02-24
Accepted
2021-02-24 17:03:22
Documents
97
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K lgnd-20201231.htm   iXBRL 10-K 3699258
2 EX-4.3 exhibit43_ligand-descripti.htm EX-4.3 28877
3 EX-10.1 exhibit101_ligand-2002stoc.htm EX-10.1 141487
4 EX-10.67 exhibit1067_bondhedgexbarc.htm EX-10.67 31645
5 EX-10.68 exhibit1068.htm EX-10.68 40297
6 EX-10.69 ligand-ex1069xbondhedgeame.htm EX-10.69 45739
7 EX-10.72 ligandcydexex1072_gileadsu.htm EX-10.72 131721
8 EX-21.1 lgnd_123120xexhibit211.htm EX-21.1 17916
9 EX-23.1 lgnd_123120xexhibit231.htm EX-23.1 4938
10 EX-31.1 lgnd_123120xexhibit311.htm EX-31.1 16018
11 EX-31.2 lgnd_123120xexhibit312.htm EX-31.2 16069
12 EX-32.1 lgnd_123120xexhibit321.htm EX-32.1 13390
18 lgnd-20201231_g1.jpg GRAPHIC 21469
19 lgnd-20201231_g2.jpg GRAPHIC 90046
  Complete submission text file 0000886163-21-000050.txt   15946298

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20201231.xsd EX-101.SCH 77822
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20201231_cal.xml EX-101.CAL 156879
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20201231_def.xml EX-101.DEF 493076
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20201231_lab.xml EX-101.LAB 1133259
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20201231_pre.xml EX-101.PRE 740554
20 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20201231_htm.xml XML 2864670
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33093 | Film No.: 21674605
SIC: 2834 Pharmaceutical Preparations